Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
RESPONSE BIOMEDICAL CORP (RBM) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/02/2016 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
12/02/2016 8-K Quarterly results
12/01/2016 4 Kinnaird-Steen Barbara (CEO) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 HOLLER ANTHONY F (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 KEEGAN JOSEPH D (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 Shuster Lewis (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 SEVERSON CLINTON (Director) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 Adams William J. (CFO & Corporate Secretary) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
12/01/2016 4 Thompson Peter A. (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 4 Wang Jonathan Jian (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
12/01/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/01/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/01/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/01/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/01/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/01/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/30/2016 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
11/15/2016 8-K Form 8-K - Current report
11/14/2016 10-Q Quarterly Report for the period ended September 30, 2016
08/16/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/16/2016 8-K Quarterly results
Docs: "Response Biomedical Corp. Announces Second Quarter 2016 Financial Results and Filing of Definitive Proxy Statement for Special Meeting of Shareholders VANCOUVER, British Columbia – August 12, 2016 - Response Biomedical Corp. a commercial stage in-vitro medical device company with products for the laboratory and point of care markets, today reported financial results for its second quarter and six months ended June 30, 2016. Total revenue for the second quarter of 2016 was $1.3M and totaled $3.5M for the first half of 2016, a reduction of 69% and 55% respectively relative to the the comparable periods of 2015. While our sales to our China distributors have suffered during the transition to our new distribution network, our sales in the rest of the world continue to see year over year growt..."
08/15/2016 10-Q Quarterly Report for the period ended June 30, 2016
08/11/2016 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers [Amend]
08/11/2016 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
08/04/2016 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers [Amend]
08/04/2016 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
07/25/2016 SC 13E3/A Form SC 13E3/A - Going private transaction by certain issuers [Amend]
07/25/2016 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
06/24/2016 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition
06/20/2016 4 Wang Jonathan Jian (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
Txns: Bought 556,339 shares @ $0.56, valued at $311.5k
Bought 5,294 shares @ $0.56, valued at $3k
Bought 331,225 shares @ $0.56, valued at $185.5k
06/20/2016 4 Thompson Peter A. (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
Txns: Bought 556,339 shares @ $0.56, valued at $311.5k
Bought 5,294 shares @ $0.56, valued at $3k
Bought 331,225 shares @ $0.56, valued at $185.5k
06/20/2016 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on RESPONSE BIOMEDICAL CORP
Txns: Bought 556,339 shares @ $0.56, valued at $311.5k
Bought 5,294 shares @ $0.56, valued at $3k
Bought 331,225 shares @ $0.56, valued at $185.5k
06/20/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy